Professor Amira Guirguis, Chair of the Royal Pharmaceutical Society’s (RPS) Science and Research Committee and RPS Fellow, has been appointed to the prestigious Advisory Council on the Misuse of Drugs (ACMD).

The Advisory Council is an independent expert body that advises government on the control of dangerous or otherwise harmful drugs, including their classification and scheduling under the Misuse of Drugs Act 1971 and its regulations.

Paul Bennett, CEO of RPS, said:

“We are delighted and very proud of Professor Guirguis’s appointment to the ACMD, which provides advice to government, carries out in-depth enquiries and influences drugs policy in the UK.

“This appointment acknowledges her expertise, dedication and commitment to evidence-based science at the highest level. I’d like to offer my congratulations and wish her every success in this important role.”

Find out more about the RPS Science and Research Committee.

More about the ACMD.

Read more RPS news stories.